• Enhances the immune system
• Fights abnormal cellular growth and differentiation
• Blocks bacterial and viral growth
• Increases levels of antioxidants
Serving Size: 1 Rounded Scoop (~30 g)
Energy … 116 Calories/486 kJ
Calories from Fat … 6 Calories/25 kJ
Proteins … 25 g
Whey protein … 20 g*
Lactoferrin … 4.8 g
Alpha-lactalbumin … 3.9 g
Glycomacropeptides … 3.0 g
Carbohydrates … 0.6 g
Sugars … 0.6 g
Fibre … 0.0 g
Fat … 1.0 g
Saturated Fat … 0.6 g
Calcium … 150 mg
Sodium … 70 mg
*from 12.8 g of whey protein isolate (84% protein) and 12.6 g whey protein concentrate (74% protein).Ingredients: Cross-flow microfiltered whey protein isolate and concentrate, lactoferrin isolate, soy lecithin.
Typical Amino Acid Profile Per 30g serving
Essential Amino Acids … 12 g
Isoleucine (BCAA) … 1.37 g
Leucine (BCAA) … 2.59 g
Valine (BCAA) … 1.42 g
Phenylalanine … 0.86 g
Methionine … 0.47 g
Lysine … 2.28 g
Tryptophan … 0.48 g
Threonine … 1.60 g
Histidine … 0.52 g
Non Essential Amino Acids … 13 g
Alanine … 1.22 g
Arginine … 0.86 g
Aspartic Acid … 2.52 g
Cysteine … 0.69 g
Glutamic Acid … 3.68 g
Glycine … 0.54 g
Proline … 1.63 g
Serine … 1.16 g
Tyrosine … 0.79 g
AOR Guarantees: Some ingredients are processed in a facility that also processes wheat, corn, nuts, sesame seeds, eggs, fish and shellfish. While none of these are added to this product, traces may be present. Contains no peanuts, sulphites or mustard.
What Is It?
Lactoferrin Ultra is an advanced whey protein formula designed to support and enhance the immune system. It is composed of a mixture of high-alphalactalbumin whey protein isolate and concentrate to which bovine lactoferrin has been added. While lactoferrin makes up only about 1% of the total protein content in most whey proteins products, AOR's Lactoferrin Ultra contains a whopping 20%.
What Does It Do?
Primary Uses: Numerous studies have documented that lactoferrin is beneficial for the immune system; it can help prevent infections and provide support during conventional cancer treatments. It activates the body's primary defenses, stimulates the immune response and enhances the killing power of cells such as macrophages and neutrophils which are responsible for attacking invaders and abnormal cells. Animal studies confirm that the combination of lactoferrin and chemotherapy is more effective than either treatment alone. Lactoferrin can therefore be used to increase the effectiveness of conventional treatments and also to prevent secondary infections. This is a significant advantage because infections secondary to immune dysfunction are a leading cause of mortality in patients receiving radiation or chemotherapy treatments. Lactoferrin Ultra contains 89% protein by weight. In cancer patients, the ability to maintain adequate nutrition is essential for a favorable prognosis, and proteins are particularly important to prevent the development of cancer cachexia, a condition characterized by weight loss, muscular atrophy, weakness and anorexia. Lactoferrin also boosts immunity by increasing glutathione levels, a powerful antioxidant.
Secondary Uses: Recent research has shown that, although they are very similar, bovine lactoferrin is in fact a more potent inhibitor of certain human viruses than human lactoferrin.
Who Should Take It?
Those requiring powerful immune system support and supplementary protein during weakened conditions and illness will greatly benefit from adding Lactoferrin Ultra to their diet.
Adult Dosage: Mix 1 scoop per day with your favorite beverage or as directed by a qualified health practitioner. Stir with a spoon for 30 seconds. Take a few hours before or after taking other medications.
Consult a health care practitioner prior to use if you have liver or kidney disease, if you have been instructed to follow a low protein diet or for use beyond 8 weeks. May cause mild gastrointestinal disturbances. Use with caution if you are allergic to dairy or soy.
Pregnancy/Nursing: Consult a health care practitioner prior to use
Bounous G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res. 2000 Nov-Dec;20(6C):4785-92.
Brinkmann CR, Thiel S, Larsen MK, Petersen TE, Jensenius JC, Heegaard CW. Preparation and comparison of cytotoxic complexes formed between oleic acid and either bovine or human α -lactalbumin. J Dairy Sci. 2011 May;94(5):2159-70.
Brock JH. The physiology of lactoferrin. Biochem Cell Biol. 2002;80(1):1-6.
Digumarti R, Wang Y, Raman G, Doval DC, Advani SH, Julka PK, Parikh PM, Patil S, Nag S, Madhavan J, Bapna A, Ranade AA, Varadhachary A, Malik R. A randomized, double-blind, placebo-controlled, phase II study of oral talactoferrin in combination with carboplatin and paclitaxel in previously untreated locally advanced or metastatic non-small cell lung cancer. J Thorac Oncol. 2011 Jun;6(6):1098-103.
Hayes TG, Falchook GS, Varadhachary A. Phase IB trial of oral talactoferrin in the treatment of patients with metastatic solid tumors. Invest New Drugs. 2010 Apr;28(2):156-62.
Hayes TG, Falchook GF, Varadhachary GR, Smith DP, Davis LD, Dhingra HM, Hayes BP, Varadhachary A. Phase I trial of oral talactoferrin alfa in refractory solid tumors. Invest New Drugs. 2006 May;24(3):233-40.
Jonasch E, Stadler WM, Bukowski RM, Hayes TG, Varadhachary A, Malik R, Figlin RA, Srinivas S. Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma. Cancer. 2008 Jul 1;113(1):72-7.
Kennedy RS, Konok GP, Bounous G, Baruchel S, Lee TD. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: a phase I-II clinical study. Anticancer Res. 1995 Nov-Dec;15(6B):2643-9.
Kozu T, Iinuma G, Ohashi Y, Saito Y, Akasu T, Saito D, Alexander DB, Iigo M, Kakizoe T, Tsuda H. Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial. Cancer Prev Res (Phila). 2009 Nov;2(11):975-83.
Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica. 1995 May-Jun;80(3):252-67.
Mistry N, Drobni P, Naslund J, Sunkari VG, Jenssen H, Evander M. The anti-papillomavirus activity of human and bovine lactoferricin. Antiviral Res. 2007 Apr 20
Mossberg AK, Wullt B, Gustafsson L, MÅnsson W, Ljunggren E, Svanborg C. Bladder cancers respond to intravesical instillation of HAMLET (human alpha-lactalbumin made lethal to tumor cells). Int J Cancer. 2007 Sep 15;121(6):1352-9.
Parikh PM, Vaid A, Advani SH, Digumarti R, Madhavan J, Nag S, Bapna A, Sekhon JS, Patil S, Ismail PM, Wang Y, Varadhachary A, Zhu J, Malik R. Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy. J Clin Oncol. 2011 Nov 1;29(31):4129-36.
Parodi PW. A Role for Milk Proteins and their Peptides in Cancer Prevention. Curr Pharm Des. 2007;13(8):813-28.
Shimamura M, Yamamoto Y, Ashino H, Oikawa T, Hazato T, Tsuda H, Iigo M. Bovine lactoferrin inhibits tumor-induced angiogenesis. Int J Cancer. 2004 Aug 10;111(1):111-6.
Sternhagen LG, Allen JC. Growth rates of a human colon adenocarcinoma cell line are regulated by the milk protein alpha-lactalbumin. Adv Exp Med Biol. 2001;501:115-20.
Tsuda H, Sekine K, Fujita K, Ligo M. Cancer prevention by bovine lactoferrin and underlying mechanisms–a review of experimental and clinical studies. Biochem Cell Biol. 2002;80(1):131-6.
Tsuda H, Sekine K, Takasuka N, Toriyama-Baba H, Iigo M. Prevention of colon carcinogenesis and carcinoma metastasis by orally administered bovine lactoferrin in animals. Biofactors. 2000;12(1-4):83-8.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.